How should arterial insufficiency be interpreted on penile Doppler ultrasound in a man with vasculogenic erectile dysfunction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpreting Arterial Insufficiency on Penile Doppler Ultrasound in Vasculogenic ED

Arterial insufficiency is diagnosed when peak systolic velocity (PSV) falls below 30–35 cm/s after intracavernosal injection of a vasoactive agent, with severe arterial disease indicated by PSV <25 cm/s. 1, 2

Critical Technical Requirements for Accurate Interpretation

Before interpreting any Doppler parameters, you must confirm complete cavernosal smooth muscle relaxation—the entire accuracy of penile Doppler depends on this single factor. 1

Achieving Adequate Pharmacologic Stimulation

  • Standard protocol: Begin with intracavernosal alprostadil 10–20 μg and wait at least 3 minutes before initial measurements 3
  • Redosing is mandatory when initial response is inadequate—use a systematic escalation protocol (5 μg increments up to 20 μg maximum) to avoid false-positive diagnoses of venous leak 3
  • Phentolamine 2 mg should be administered if venogenic ED is suspected after maximal alprostadil dosing, as this unmasks "false-positive" venous leakage in approximately 50% of cases 3
  • Continue scanning for up to 30 minutes, obtaining measurements alternately from both cavernosal arteries 3

Diagnostic Thresholds for Arterial Insufficiency

Peak Systolic Velocity (PSV)

The primary marker of arterial inflow has well-established cutoffs:

  • Normal arterial function: PSV >30–35 cm/s 1, 2
  • Mild-to-moderate arterial insufficiency: PSV 25–35 cm/s (mean 35 ± 16 cm/s in published cohorts) 4
  • Severe arterial insufficiency: PSV <25 cm/s (mean 7 ± 8 cm/s in severe cases) 4

Acceleration Time (AT)

An underutilized but valuable parameter:

  • Arterial insufficiency indicated when AT >110 milliseconds 2
  • This reflects delayed arterial upstroke and impaired flow dynamics 2

Asymmetric Arterial Response

  • Significant side-to-side PSV difference (>10–15 cm/s between right and left cavernosal arteries) suggests unilateral arterial disease and is more common in mild-to-moderate insufficiency 4
  • Unilateral disease was present in 71% of patients with angiographically confirmed arterial obstructions 5

Critical Anatomic Consideration: Location Matters

A major pitfall: PSV varies dramatically by measurement location along the cavernosal artery. 6

  • At the penile crus: Mean PSV 52.9 ± 20.2 cm/s 6
  • Proximal cavernosal artery: Mean PSV 29.5 ± 15.1 cm/s 6
  • Mid-shaft cavernosal artery: Mean PSV 21.6 ± 10.6 cm/s 6

This anatomic variation can completely change your diagnosis—a patient may appear normal at the crus but severely insufficient at mid-shaft. 6 Future standardization should specify measurement location, but until then, document the exact anatomic site where you obtained each velocity measurement. 6

Supplementary Markers of Arterial Disease

Power Doppler Assessment

  • Failure to visualize helicine arteries on power Doppler mode, combined with incomplete penile rigidity, supports arterial insufficiency even when PSV is borderline 2

Resistance Index (RI)

  • Calculated as (PSV - EDV)/PSV 3
  • While primarily used for venogenic assessment, persistently low RI may reflect poor arterial compliance 3

Arterial Diameter Changes

  • Contrary to older teaching, cavernosal artery diameter and post-injection diameter increase do NOT predict arterial patency and should not be used diagnostically 4

Confirming Maximal Smooth Muscle Relaxation

You cannot interpret arterial parameters without confirming adequate smooth muscle relaxation:

  • End-diastolic velocity (EDV) should be negative (reversal of flow in diastole) when complete relaxation is achieved 6
  • Erection Hardness Score (EHS) should reach grade 3–4 (sufficient for penetration) 3
  • If rigidity remains inadequate despite 20 μg alprostadil, administer phentolamine 2 mg before concluding arterial insufficiency 3

Common Pitfalls to Avoid

  1. Diagnosing arterial disease without maximal vasodilation: Always complete the redosing protocol before finalizing your interpretation 1, 3

  2. Ignoring measurement location: A PSV of 28 cm/s at the crus is abnormal, but the same value at mid-shaft may be normal 6

  3. Overlooking unilateral disease: Always compare both sides—asymmetric flow patterns indicate focal arterial pathology amenable to intervention 4, 5

  4. Premature diagnosis of venous leak: Elevated EDV often normalizes after phentolamine administration in patients with incomplete smooth muscle relaxation 3

Clinical Implications of Arterial Insufficiency

When arterial insufficiency is confirmed:

  • First-line therapy remains PDE5 inhibitors with systematic dose titration, as these can still provide benefit even with reduced arterial inflow 7
  • Cardiovascular risk assessment is mandatory—arterial ED predicts future cardiac events with strength comparable to smoking or family history of MI 7
  • Specialized interventions may be considered: intracavernosal injection therapy shows mean 3-point IIEF-EF improvement over placebo 7, and low-intensity shockwave therapy offers potential disease modification in mild vasculogenic ED 7
  • Endovascular revascularization should be considered in young men (<40 years) with isolated arterial lesions after pelvic trauma, confirmed by selective angiography—89% of non-responders to alprostadil have obstructions amenable to intervention 5
  • The most commonly affected vessels are the internal pudendal artery (65%) and common penile artery (64%) 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.